One-year experience with the platelet glycoprotein IIb/IIIa antagonist tirofiban and heparin during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia type II
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.